Your Article Summary
See Latest ArticlesSafety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
JACC - Journal of the American College of Cardiology, 08/27/08
White HD et al. - Bivalirudin compared with UFH or enoxaparin plus a GP IIb/IIIa inhibitor results in similar rates of composite ischemia and mortality at 1 year in moderate- and high-risk ACS patients undergoing PCI.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/15/09
Today in Coronary Artery Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Integrative Predictive Model of Coronary Artery Calcification in Atherosclerosis
Circulation, 12/15/09
Relation of Nausea and Vomiting in Acute Myocardial Infarction to Location of the Infarct
The American Journal of Cardiology, 12/15/09
Usefulness of Fragmented QRS on a 12-Lead Electrocardiogram in Acute Coronary Syndrome for Predicting Mortality
The American Journal of Cardiology, 12/15/09
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Choice of Reperfusion Strategy at Hospitals With Primary Percutaneous Coronary Intervention. A National Registry of Myocardial Infarction Analysis
Circulation, 12/15/09
Patient Comprehension of an Interactive, Computer-Based Information Program for Cardiac Catheterization
Archives of Internal Medicine, 12/14/09
Prehospital 12-Lead ECG to Triage ST-Elevation Myocardial Infarction and Emergency Department Activation of the Infarct Team Significantly Improves Door-to-Balloon Times
Circulation: Cardiovascular Interventions, 12/03/09